Procter & Gamble Health Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar' 24	Dec' 23	Sep' 23	Jun' 23	Mar' 23

Sales

252.48

309.97

304.93

301.18

320.92

Operating profit

67.44

101.65

88.66

45.22

79.66

Interest

0.15

0.19

0.18

0.17

0.21

Gross profit

69.56

106.64

94.53

50.51

84.42

EPS (Rs)

28.05

43.42

39.50

17.96

35.66

Other income

2.27

5.18

6.05

5.46

4.97

Stock adjustment

-1.93

11.15

-1.59

13.18

15.95

Raw material

64.66

70.84

87.31

74.31

63.62

Power and fuel

-

-

-

-

-

Employee expenses

48.46

57.43

60.64

55.40

60.73

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

73.85

68.90

69.91

113.07

103.09

Provisions made

-

-

-

-

-2.13

Depreciation

6.84

6.92

6.48

6.38

5.89

Taxation

16.16

27.65

22.48

14.31

19.34

Net profit / loss

46.56

72.07

65.57

29.82

59.19

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

16.60

16.60

16.60

16.60

16.60

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

26.71

32.79

29.08

15.01

24.82

GPM (%)

27.31

33.84

30.40

16.47

25.90

NPM (%)

18.28

22.87

21.08

9.72

18.16